Back to School: How biopharma can reboot drug development. Access exclusive analysis here

DIST_0629_pnas.1909649117

Antisense oligos against transcription factor DUX4 for a muscular dystrophy

Aug 27, 2020 | 9:40 PM GMT

DISEASE CATEGORY: Musculoskeletal

INDICATION: Muscular dystrophy

Antisense

Read the full 201 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE